Galectin-3 in bone tumor microenvironment: a beacon for individual skeletal metastasis management
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Galectin-3 in bone tumor microenvironment: a beacon for individual skeletal metastasis management
Authors
Keywords
Galectin-3, Bone tumor microenvironment, Bone metastasis, Personalized medicine
Journal
CANCER AND METASTASIS REVIEWS
Volume 35, Issue 2, Pages 333-346
Publisher
Springer Nature
Online
2016-04-11
DOI
10.1007/s10555-016-9622-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- NCCN Task Force Report: Bone Health in Cancer Care
- (2017) Julie R. Gralow et al. Journal of the National Comprehensive Cancer Network
- Galectin-3 Cleavage Alters Bone Remodeling: Different Outcomes in Breast and Prostate Cancer Skeletal Metastasis
- (2016) Kosei Nakajima et al. CANCER RESEARCH
- Galectin-1 and galectin-3: Plausible tumour markers for oral squamous cell carcinoma and suitable targets for screening high-risk population
- (2015) Sadhna Aggarwal et al. CLINICA CHIMICA ACTA
- 11C-Choline PET/CT Identifies Osteoblastic and Osteolytic Lesions in Patients with Metastatic Prostate Cancer
- (2015) Francesco Ceci et al. CLINICAL NUCLEAR MEDICINE
- Inhibition of Prostate Cancer Bone Metastasis by Synthetic TF Antigen Mimic/Galectin-3 Inhibitor Lactulose-l-Leucine
- (2015) Olga V. Glinskii et al. NEOPLASIA
- Expression and clinical significance of galectin-3 in osteosarcoma
- (2014) Xuesong Zhou et al. GENE
- Galectin-3 drives glycosphingolipid-dependent biogenesis of clathrin-independent carriers
- (2014) Ramya Lakshminarayan et al. NATURE CELL BIOLOGY
- Natural History of Malignant Bone Disease in Hepatocellular Carcinoma: Final Results of a Multicenter Bone Metastasis Survey
- (2014) Daniele Santini et al. PLoS One
- Galectin-3 Inhibits Osteoblast Differentiation through Notch Signaling
- (2014) Kosei Nakajima et al. NEOPLASIA
- Why anti-Bcl-2 clinical trials fail: a solution
- (2013) Y. Harazono et al. CANCER AND METASTASIS REVIEWS
- Natural History of Malignant Bone Disease in Gastric Cancer: Final Results of a Multicenter Bone Metastasis Survey
- (2013) Nicola Silvestris et al. PLoS One
- Natural history of bone metastasis in colorectal cancer: final results of a large Italian bone metastases study
- (2012) D. Santini et al. ANNALS OF ONCOLOGY
- Prostate Cancer Cells and Bone Stromal Cells Mutually Interact with Each Other through Bone Morphogenetic Protein-mediated Signals
- (2012) Hikaru Nishimori et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Overall Survival Improvement in Patients with Lung Cancer and Bone Metastases Treated with Denosumab Versus Zoledronic Acid: Subgroup Analysis from a Randomized Phase 3 Study
- (2012) Giorgio Vittorio Scagliotti et al. Journal of Thoracic Oncology
- Disseminated Prostate Cancer Cells Can Instruct Hematopoietic Stem and Progenitor Cells to Regulate Bone Phenotype
- (2012) J. Joseph et al. MOLECULAR CANCER RESEARCH
- The differentiation stage of p53-Rb-deficient bone marrow mesenchymal stem cells imposes the phenotype of in vivo sarcoma development
- (2012) R Rubio et al. ONCOGENE
- Oral squamous carcinoma cells secrete RANKL directly supporting osteolytic bone loss
- (2012) Xiaoyi Zhang et al. ORAL ONCOLOGY
- VCAM-1 Promotes Osteolytic Expansion of Indolent Bone Micrometastasis of Breast Cancer by Engaging α4β1-Positive Osteoclast Progenitors
- (2011) Xin Lu et al. CANCER CELL
- Tumor-Derived Jagged1 Promotes Osteolytic Bone Metastasis of Breast Cancer by Engaging Notch Signaling in Bone Cells
- (2011) Nilay Sethi et al. CANCER CELL
- The bone marrow compartment is modified in the absence of galectin-3
- (2011) C. Brand et al. CELL AND TISSUE RESEARCH
- Steps in prostate cancer progression that lead to bone metastasis
- (2011) Jung-Kang Jin et al. INTERNATIONAL JOURNAL OF CANCER
- Human prostate cancer metastases target the hematopoietic stem cell niche to establish footholds in mouse bone marrow
- (2011) Yusuke Shiozawa et al. JOURNAL OF CLINICAL INVESTIGATION
- Randomized, Double-Blind Study of Denosumab Versus Zoledronic Acid in the Treatment of Bone Metastases in Patients With Advanced Cancer (Excluding Breast and Prostate Cancer) or Multiple Myeloma
- (2011) David H. Henry et al. JOURNAL OF CLINICAL ONCOLOGY
- Rapamycin inhibits osteoclast formation in giant cell tumor of bone through the C/EBPβ - MafB axis
- (2011) Jeske J. Smink et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study
- (2011) Karim Fizazi et al. LANCET
- Denosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer: results of a phase 3, randomised, placebo-controlled trial
- (2011) Matthew R Smith et al. LANCET
- Building strong bones: molecular regulation of the osteoblast lineage
- (2011) Fanxin Long NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Advances in osteoclast biology: old findings and new insights from mouse models
- (2011) James R. Edwards et al. Nature Reviews Rheumatology
- The cellular and molecular mechanisms of bone invasion by oral squamous cell carcinoma
- (2011) E Jimi et al. ORAL DISEASES
- Galectin 3 aggravates joint inflammation and destruction in antigen-induced arthritis
- (2010) Huamei Forsman et al. ARTHRITIS AND RHEUMATISM
- GCS-100, a novel galectin-3 antagonist, modulates MCL-1, NOXA, and cell cycle to induce myeloma cell death
- (2010) M. J. Streetly et al. BLOOD
- Expression of Mac-2 antigen in the preosteoclast and osteoclast identified in the op/op mouse injected with macrophage colony-stimulating factor
- (2010) Shumpei Niida et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Tumor-derived syndecan-1 mediates distal cross-talk with bone that enhances osteoclastogenesis
- (2010) Thomas Kelly et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study
- (2010) Alison T. Stopeck et al. JOURNAL OF CLINICAL ONCOLOGY
- Interleukin-34 is expressed by giant cell tumours of bone and plays a key role in RANKL-induced osteoclastogenesis
- (2010) Marc Baud'Huin et al. JOURNAL OF PATHOLOGY
- Zoledronic Acid Use in Patients With Bone Metastases From Renal Cell Carcinoma or Bladder Cancer
- (2010) Fred Saad et al. SEMINARS IN ONCOLOGY
- Zoledronic Acid in the Treatment of Bone Metastases from Differentiated Thyroid Carcinoma
- (2010) Yorihisa Orita et al. THYROID
- Osteoimmunology and the effects of the immune system on bone
- (2009) Hiroshi Takayanagi Nature Reviews Rheumatology
- Racial Disparity in Breast Cancer and Functional Germ Line Mutation in Galectin-3 (rs4644): A Pilot Study
- (2008) V. Balan et al. CANCER RESEARCH
- Prostate Cancer Induces Bone Metastasis through Wnt-Induced Bone Morphogenetic Protein-Dependent and Independent Mechanisms
- (2008) J. Dai et al. CANCER RESEARCH
- Tumor expressed PTHrP facilitates prostate cancer-induced osteoblastic lesions
- (2008) Jinhui Liao et al. INTERNATIONAL JOURNAL OF CANCER
- Expression of Osteoclast Differentiation Signals by Stromal Elements of Giant Cell Tumors
- (2006) Gerald J. Atkins et al. JOURNAL OF BONE AND MINERAL RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started